Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-231682
Filing Date
2021-07-30
Accepted
2021-07-30 17:20:59
Documents
4
Effectiveness Date
2021-07-30

Document Format Files

Seq Description Document Type Size
1 S-8 d208575ds8.htm S-8 71785
2 EX-5.1 d208575dex51.htm EX-5.1 6790
3 EX-23.1 d208575dex231.htm EX-23.1 1376
4 GRAPHIC g208575dsp1.jpg GRAPHIC 3958
  Complete submission text file 0001193125-21-231682.txt   86584
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

EIN.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258337 | Film No.: 211133549
SIC: 2836 Biological Products, (No Diagnostic Substances)